Results
20
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
20 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €692.40 | 7.4% | 107.4% | €30.1b | €725.20 | PE43.9x | E29.9% | 0.8% | Capital Goods | ||
3SQ1 | €10.40 | -17.5% | -55.6% | €26.9m | n/a | PE26.3x | n/a | n/a | Capital Goods | ||
FPH | €2.52 | 0% | -10.0% | €39.4m | €5.80 | PE3x | E-29.8% | 0% | Commercial Services | ||
AOF | €110.20 | -2.0% | -3.3% | €1.8b | €125.64 | PE40x | E6.9% | 1.5% | Software | ||
SMB | €45.00 | 0% | 4.7% | €58.4m | n/a | PE7x | n/a | 1.8% | Food, Beverage & Tobacco | ||
CTNK | €3.43 | -0.6% | -30.0% | €73.0m | n/a | PE4.2x | n/a | n/a | Semiconductors | ||
PEH | €23.20 | 1.8% | 8.4% | €37.6m | n/a | PE9.2x | n/a | 8.2% | Diversified Financials | ||
ACT | €61.60 | -3.4% | 147.4% | €626.9m | €74.18 | PE12.5x | E12.8% | 1.9% | Materials | ||
MUM | €52.60 | -2.0% | 1.0% | €893.8m | €71.00 | PE28x | E13.3% | 3.1% | Software | ||
T3T1 | €5.30 | 0% | -2.8% | €19.6m | n/a | PE9.7x | n/a | n/a | Software | ||
YOC | €15.20 | 2.0% | 10.9% | €52.8m | €26.00 | PE14x | E20.1% | n/a | Media | ||
EKT | €47.40 | -0.2% | -38.6% | €656.8m | €132.50 | PE8.9x | E18.1% | 2.5% | Capital Goods | ||
N9H | €0.0065 | 0% | 44.4% | €2.1m | n/a | PE0.2x | n/a | n/a | Real Estate Management and Development | ||
HMU | €36.20 | 16.8% | 61.6% | €164.5m | €36.00 | PE13x | E8.0% | 2.5% | Capital Goods | ||
TUI1 | €7.76 | 2.9% | 21.2% | €3.9b | €10.12 | PE7.8x | E17.1% | 0% | Consumer Services | ||
93M1 | €23.00 | 0.9% | 42.4% | €98.5m | €108.00 | PE0.8x | E-65.7% | 5.2% | Pharmaceuticals & Biotech | ||
EDL | €4.38 | -0.9% | -11.3% | €93.2m | €7.50 | PE7.6x | E-0.4% | 6.8% | Media | ||
SAX | €54.45 | -2.8% | 1.8% | €3.0b | €70.79 | PE26.3x | E27.2% | 3.4% | Media | ||
OT8 | €1.65 | -1.0% | n/a | €195.8m | €2.50 | PE9.4x | E29.7% | n/a | Diversified Financials | ||
LIK | €336.00 | 0% | 18.3% | €98.5m | €641.00 | PE23x | S16.5% | n/a | Healthcare |